Sign Out
In the regular treatment of asthma, where use of a combination product (long-acting beta-2 agonist and inhaled corticosteroid) is appropriate.
Patients not adequately controlled with inhaled corticosteroids and as needed inhaled short acting beta-2 agonist.
Patients already adequately controlled on both inhaled corticosteroid and long-acting beta-2 agonist.
Continue with Google